StockCIK 1636282

Spyre Therapeutics, Inc. (SYRE): Insider Trades and Fund Holdings

In the past 12 months, Spyre Therapeutics, Inc. insiders reported 0 open-market purchases worth $0 and 9 sales worth $12.3M; 9 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$12.3MSold by insiders, 12 months

0Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 2, 2026.

Recent SYRE insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Oct 2	Oct 1	Heidy King-JonesSee Remarks	See Remarks	▼ SELL10b5-1	28,933	91.03	$2.63M	−91%	Form 4 ↗
Oct 2	Sep 30	Scott L. BurrowsCFO	CFO	▼ SELL10b5-1	17,500	89.89	$1.57M	−18%	Form 4 ↗
Oct 2	Oct 1	Cameron TurtleCEO	CEO	▼ SELL10b5-1	15,000	92.01	$1.38M	−2.7%	Form 4 ↗
Oct 2	Oct 1	Scott L. BurrowsCFO	CFO	▼ SELL10b5-1	7,500	91.83	$689K	−8.6%	Form 4 ↗
Sep 3	Sep 1	Heidy King-JonesSee Remarks	See Remarks	▼ SELL10b5-1	27,999	87.31	$2.44M	−91%	Form 4 ↗
Sep 3	Sep 2	Scott L. BurrowsCFO	CFO	▼ SELL10b5-1	18,232	89.35	$1.63M	−19%	Form 4 ↗
Sep 3	Sep 1	Cameron TurtleCEO	CEO	▼ SELL10b5-1	15,000	87.29	$1.31M	−2.6%	Form 4 ↗
Sep 3	Sep 1	Scott L. BurrowsCFO	CFO	▼ SELL10b5-1	7,500	87.31	$655K	−7.1%	Form 4 ↗
Sep 3	Sep 2	Heidy King-JonesSee Remarks	See Remarks	▼ SELL10b5-1	400	90.00	$36K	−12%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Bought	Sells	Sold	Latest
Heidy King-Jones	See Remarks	$0	3	$5.11M	Oct 2, 2026
Scott L. Burrows	CFO	$0	4	$4.55M	Oct 2, 2026
Cameron Turtle	CEO	$0	2	$2.69M	Oct 2, 2026

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →